radiopharmaceutical therapy

Open Access
Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy
Emma Mellhammar, Magnus Dahlbom, Oskar Vilhelmsson-Timmermand and Sven-Erik Strand

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1632-1637; DOI: https://doi.org/10.2967/jnumed.123.265523
You have access
Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy
Julie Bolcaen, Mohamed A. Gizawy, Samantha Y.A. Terry, António Paulo, Bart Cornelissen, Aruna Korde, Jonathan Engle, Valery Radchenko and Roger W. Howell

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1344-1351; DOI: https://doi.org/10.2967/jnumed.122.265039
Open Access
An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose
Julia Brosch-Lenz, Suqi Ke, Hao Wang, Eric Frey, Yuni K. Dewaraja, John Sunderland and Carlos Uribe

Journal of Nuclear Medicine July 1, 2023, 64 (7) 1109-1116; DOI: https://doi.org/10.2967/jnumed.122.265094
You have access
A Realistic Multiregion Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy
Clarita Saldarriaga Vargas, Lara Struelens, Matthias D’Huyvetter, Vicky Caveliers and Peter Covens

Journal of Nuclear Medicine March 1, 2023, 64 (3) 493-499; DOI: https://doi.org/10.2967/jnumed.122.264453
You have access
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose ²¹¹At-Labeled Anti-HER2 Single-Domain Antibody Fragment
Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan and Michael R. Zalutsky

Journal of Nuclear Medicine January 1, 2023, 64 (1) 124-130; DOI: https://doi.org/10.2967/jnumed.122.264071
You have access
SIR-Spheres Activity Measurements Reveal Systematic Miscalibration
Stephen A. Graves, Molly Martin, Ashok Tiwari, Michael Merrick and John Sunderland

Journal of Nuclear Medicine August 1, 2022, 63 (8) 1131-1135; DOI: https://doi.org/10.2967/jnumed.121.262650
You have access
An Improved ²¹¹At-Labeled Agent for PSMA-Targeted α-Therapy
Ronnie C. Mease, Choong Mo Kang, Vivek Kumar, Sangeeta Ray Banerjee, Il Minn, Mary Brummet, Kathleen L. Gabrielson, Yutian Feng, Andrew Park, Ana P. Kiess, George Sgouros, Ganesan Vaidyanathan, Michael R. Zalutsky and Martin G. Pomper

Journal of Nuclear Medicine February 1, 2022, 63 (2) 259-267; DOI: https://doi.org/10.2967/jnumed.121.262098
You have access
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
George Sgouros, Yuni K. Dewaraja, Freddy Escorcia, Stephen A. Graves, Thomas A. Hope, Amir Iravani, Neeta Pandit-Taskar, Babak Saboury, Sara St. James and Pat B. Zanzonico

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 12S-22S; DOI: https://doi.org/10.2967/jnumed.121.262750
You have access
Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
Jacek Capala, Stephen A. Graves, Aaron Scott, George Sgouros, Sara St. James, Pat Zanzonico and Brian E. Zimmerman

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 3S-11S; DOI: https://doi.org/10.2967/jnumed.121.262749
You have access
Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice
Neeta Pandit-Taskar, Amir Iravani, Dan Lee, Heather Jacene, Dan Pryma, Thomas Hope, Babak Saboury, Jacek Capala and Richard L. Wahl

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 60S-72S; DOI: https://doi.org/10.2967/jnumed.121.262977

Main menu

User menu

Search

radiopharmaceutical therapy

Pages